IL6R and neoplasm: Then, tumor-tropic BM-MSCs circulated to primary sites and triggered CD151<sup>+</sup>/CD38<sup>+</sup> cells acquiring EMT-associated CSC properties through IL6R/pY705-STAT3 signaling to promote tumor initiation and were also attracted by and migrated towards the premetastatic niche.